Tolerability of sorafenib in the treatment of hepatocellular carcinoma (HCC) in patients with Child A and B liver cirrhosis

被引：0
|
作者：
Schuette, K.
Zimmermann, L.
Bornschein, J.
Huster, D.
Csepregi, A.
Malfertheiner, P.
机构：
[1] Univ Magdeburg, D-39106 Magdeburg, Germany
[2] Hufeland Klinikum, Bad Langensalza, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15593
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Experience with Sorafenib treatment of Hepatocellular carcinoma in (Hcc) in real life patients in Three Brazilian centeres
    Alves, Rogerio C.
    Alves, Daniele E.
    Viana, Monica V.
    Fonseca, Eduardo A.
    Matos, Carla A.
    Kondo, Mario
    Malzyner, Artur
    Gampel, Otavio
    Poletti, Paula B.
    HEPATOLOGY, 2013, 58 : 1275A - 1275A
  • [42] PATTERNS OF TOXICITY AND TREATMENT DISCONTINUATION IN EGYPTIAN HEPATOCELLULAR CARCINOMA (HCC) PATIENTS RECEIVING SORAFENIB MONOTHERAPY
    Omar, Abdel-Rahman
    Manal, Abdel Wahab
    Sherif, Abdel Wahab
    Mohammed, Shaker
    Mohammed, Elbassiouny
    Mahmoud, Ellithy
    ANNALS OF ONCOLOGY, 2014, 25 : 64 - 64
  • [43] Sorafenib Therapy in HIV-infected Patients with Hepatocellular Carcinoma (HCC)
    Kikuchi, Luciana
    Citti, Caitlin C.
    Chen, Ting-Yi
    Platt, Heather L.
    Kaplan, David E.
    Ventura-Cots, Meritxell
    Jain, Mamta K.
    Vispo, Eugenia
    Daruich, Jorge
    Nunez, Marina
    Barreiro, Pablo
    Minguez, Beatriz
    Aytaman, Ayse
    Rimland, David
    Braeu, Norbert
    HEPATOLOGY, 2015, 62 : 430A - 430A
  • [44] Efficacy and safety of sorafenib (SFN) in elderly patients with hepatocellular carcinoma (HCC)
    Gomes Da Fonseca, L.
    Nader Marta, G.
    Braghiroli, M. I.
    Hoff, P. M.
    Sabbaga, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Hepatocellular carcinoma (HCC) in a patient with cystic fibrosis and liver disease (cirrhosis)
    Pouliopoulos, Petros
    Manika, Katerina
    Faniadou, Eleni
    Galanis, Stavros
    Vasileiou, Konstantinos
    Sionidou, Maria
    Avgerinos, Antonios
    Kioumis, Ioannis
    PNEUMON, 2022, 35 (01)
  • [46] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitrios
    Thillai, Kiruthikah
    Korantzis, Ippokratis
    Chowdhury, M. H. Ruhe
    Papadatos-Pastos, Dionysios
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [47] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitris
    Thillai, Kiruthikah
    Papadatos-Pastos, Dionysios
    Chowdhury, Mahfuja Hussain Ruhe
    Korantzis, Ippokratis
    Manickavasagar, Thubeena
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Commentary: Sorafenib Use in Patients with Advanced Hepatocellular Carcinoma and Underlying Child-Pugh B Cirrhosis-Evidence and Controversy
    Zhu, Andrew X.
    Clark, Jeffrey W.
    ONCOLOGIST, 2009, 14 (01): : 67 - 69
  • [49] Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
    Woerns, Marcus Alexander
    Weinmann, Arndt
    Pfingst, Kerstin
    Schulte-Sasse, Carla
    Messow, Claudia-Martina
    Schulze-Bergkamen, Henning
    Teufel, Andreas
    Schuchmann, Marcus
    Kanzler, Stephan
    Dueber, Christoph
    Otto, Gerd
    Galle, Peter Robert
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (05) : 489 - 495
  • [50] Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by Etiology
    Nagai, Hidenari
    Mukozu, Takanori
    Kobayashi, Kojiro
    Amanuma, Makoto
    Yoshimine, Naoyuki
    Ogino, Yu
    Matsui, Daigo
    Daido, Yasuko
    Matsukiyo, Yasushi
    Matsui, Teppei
    Wakui, Noritaka
    Momiyama, Koichi
    Shinohara, Mie
    Higai, Koji
    Igarashi, Yoshinori
    ANTICANCER RESEARCH, 2019, 39 (04) : 2183 - 2191
12345